🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Sweden / NCT04519229
Enrolling by invitation Observational

Child-Parent Psychotherapy - a Feasibility Study for Children in Foster Care

NCT04519229 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2019-06-30
Last updated
2026-08-12

Condition(s) studied

Child AbuseChild NeglectPost-Traumatic Stress Disorder in ChildrenParent-Child Relations

Investigational drug(s) / intervention(s)

Child-Parent Psychotherapy

Child-Parent Psychotherapy: Relationship-based trauma focused psychotherapy for Children 0-6 years old and their caregivers. The objective is to decrease symptoms of post-traumatic tress and re-establish a secure attachment for the child and good caregiving from the caregiver/s.

Study summary

Children in foster care have an increased risk of exposure to adverse experiences during childhood and across the lifespan. In current studies of interventions children in foster care are often excluded, or they are too few to be included in statistical analyses of outcomes. As a consequence, knowledge on feasibility of treatment methods for some of the most exposed and maltreated children in society is sparse.

Child-Parent Psychotherapy (CPP) is an intervention for children 0-6 years who have been exposed to adverse and traumatic events. CPP is currently being implemented in Sweden. The aim of this study is to investigate the feasibility of CPP for children in foster care.

Eligibility

Sex
ALL
Min age
0 Years
Max age
6 Years
Healthy volunteers
No
Inclusion Criteria: * Age 0-6 years * being offered Child-Parent Psychotherapy as part of their regular treatment Exclusion Criteria: * Families in need of translator for interviews.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Research and Development, Region Kronoberg Vaxjo Sweden

More Kronoberg County Council trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04519229 on ClinicalTrials.gov ↗ ← All trials in Sweden